ESR1 and breast cancer: The detected frequency of AKT1E17K mutation in breast cancer ranges between 1.4% and 8.2%, with a mean mutation frequency of 3.8%, and is apparently restricted to estrogen receptor (ER)-positive tumors [13,16].